论文部分内容阅读
目的观察注射用牛肺表面活性剂(珂立苏)治疗新生儿呼吸窘迫综合征(RDS)的临床疗效。方法选取2015年3月-2016年3月在该院接受治疗的RDS患儿50例作为研究对象,所有患儿均给予珂立苏治疗,比较治疗后2、8、24、48h肺功能变化情况。结果 50例RDS患儿治疗后2、8、24、48h肺功能各指标均明显优于治疗前,差异有统计学意义(P<0.05)。结论 PS治疗RDS改善了患儿肺功能,值得临床推广。
Objective To observe the clinical efficacy of injecting bovine pulmonary surfactant (Ke Li Su) in the treatment of neonatal respiratory distress syndrome (RDS). Methods Fifty children with RDS who were treated in our hospital from March 2015 to March 2016 were selected as the study subjects. All children were treated with tribenuron-methyl, and the changes of lung function were compared at 2, 8, 24, 48 hours after treatment . Results 50 cases of RDS children 2,8,24,48 h after treatment were significantly better than the indicators of lung function before treatment, the difference was statistically significant (P <0.05). Conclusion PS treatment of RDS improved children’s lung function, it is worth clinical promotion.